Vanguard Australian Shares Index Etf

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

Westpac Banking Corporation

WBC

Westpac Banking Corp. engages in the provision of banking and financial services. The company is headquartered in Sydney, New South Wales and currently employs 34,749 full-time employees. The firm's segments include Consumer, which provides a range of banking products and services, including mortgages, credit cards, personal loans, and savings and at call deposits to customers in Australia; Business segment, which provides banking services and products to Australian small business, agribusiness and commercial businesses and offers savings, transaction and lending products, including specialist services; Westpac Institutional Bank (WIB), which provides a range of financial services to commercial, corporate, institutional and government customers operating in Australia and New Zealand, Westpac New Zealand segment, which provides banking and wealth products and services for consumer, business and institutional customers and specialist businesses.

Commonwealth Bank of Australia

CBA

Commonwealth Bank of Australia engages in the provision of banking and financial services. The company is headquartered in Sydney, New South Wales and currently employs 48,860 full-time employees. The firm provides retail and commercial banking services predominantly in Australia and in New Zealand through its subsidiary, ASB. The company serves approximately 16 million customers. The firm's segments include Retail Banking Services, Business Banking, Institutional Banking and Markets and New Zealand. Retail Banking services provides banking and general insurance products and services to personal and private bank customers. Business Banking serves the banking needs of business, corporate and agribusiness customers across the full range of financial services solutions, as well as providing equities trading and margin lending services through the CommSec business. Institutional Banking and Markets serves the commercial and wholesale banking needs of large corporate, institutional and government clients. New Zealand includes the banking and funds management businesses operating under the ASB brand.

ANZ Group Holdings Limited

ANZ

ANZ Group Holdings Ltd. operates as a non-operating holding company. The company operates in six divisions: Australia Retail, Australia Commercial, Institutional, New Zealand, Pacific, and Group Center. The Australia Retail division offers a range of banking services, such as home loans, deposits, credit cards and personal loans. The company also offers digital and Internet banking and phone banking. The Australia Commercial division provides a full range of banking products and financial services, including asset financing, across customer segments: small business owners and medium commercial customers. The Institutional division services government, global institutional and corporate customers across Australia, New Zealand and International. The New Zealand division provides personal banking and wealth management services. The Pacific division provides retail products for traditional relationship banking. The Group center supports the operating divisions, including technology, property, and risk management.

CSL Limited

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,000 full-time employees. The Company’s areas of focus and exploration include rare and serious diseases, influenza vaccines, plasma collection, and therapies for iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment manufactures, markets, and distributes plasma therapies (plasma products and recombinants). CSL Seqirus segment manufactures, markets, and distributes primarily influenza-related products and provides pandemic services to governments. The Company’s CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency, dialysis and nephrology and rare diseases. The Company’s geographical areas of operation include Australia, the United States of America, Germany, the United Kingdom, Switzerland, and China. CSL’s products include HIZENTRA, PRIVIGEN, IDELVION, HAEMATE, KCENTRA, HAEGARDA, ZEMAIRA/RESPREEZA, FLUAD and FLUCELVAX.